clofilium and methoxamine

clofilium has been researched along with methoxamine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunden, MN; Buchanan, LV; Gibson, JK; Kabell, G1
Bonnemain, B; Bourgoin-Balut, C; Gaillard, S; Goulas, V; Idée, JM; Lefevre, T; Mathias, C; Zamia, P1
Chow, MS; Kluger, J; White, CM; Xie, J1
Hou, CJ; Sung, RJ; Tan, HL1
Anderson, ME; Mazur, A; Roden, DM1
Al-Khalidi, H; Brooks, RR; Drexler, AP; Kostreva, DR; Maynard, AE1
Anderson, ME; Gbadebo, TD; Khoo, MS; Roden, DM; Temple, J; Trimble, RW1
Hasumi, H; Hata, Y; Kaneko, N; Matsuda, R; Shimamoto, K1
Belardinelli, L; Dhalla, AK; Robertson, C; Wang, WQ1

Other Studies

9 other study(ies) available for clofilium and methoxamine

ArticleYear
Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia.
    Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Heart Conduction System; Heart Rate; Male; Methoxamine; Phenethylamines; Piperidines; Pyridines; Quaternary Ammonium Compounds; Rabbits; Software; Sotalol; Sulfonamides; Torsades de Pointes

1993
Role of sodium in contrast medium-induced polymorphic ventricular tachycardia: results in a rabbit model of lengthened QT interval.
    Academic radiology, 1998, Volume: 5, Issue:6

    Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Contrast Media; Coronary Angiography; Coronary Vessels; Disease Models, Animal; Drug Interactions; Electrocardiography; Infusions, Intravenous; Iohexol; Ioxaglic Acid; Male; Methoxamine; Quaternary Ammonium Compounds; Rabbits; Sodium; Tachycardia, Ventricular

1998
Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model.
    Pharmacotherapy, 1999, Volume: 19, Issue:5

    Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Magnesium; Methoxamine; Quaternary Ammonium Compounds; Rabbits; Sympathomimetics; Torsades de Pointes

1999
Effects of adenosine A1-receptor activation on torsade de pointes in rabbits.
    Cardiovascular drugs and therapy, 1999, Volume: 13, Issue:5

    Topics: Adenosine; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Drug Interactions; Electrocardiography; Methoxamine; Neuroprotective Agents; Potassium Channels; Propranolol; Quaternary Ammonium Compounds; Rabbits; Torsades de Pointes

1999
Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.
    Circulation, 1999, Dec-14, Volume: 100, Issue:24

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Agonists; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Heart Rate; Isoquinolines; Long QT Syndrome; Male; Methoxamine; Quaternary Ammonium Compounds; Rabbits; Sulfonamides; Torsades de Pointes

1999
Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 2000, Volume: 223, Issue:2

    Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Female; Hemodynamics; Hydantoins; Imidazoles; Imidazolidines; Male; Methoxamine; Phenethylamines; Piperazines; Procainamide; Quaternary Ammonium Compounds; Rabbits; Sotalol; Sulfonamides

2000
Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes.
    Circulation, 2002, Feb-12, Volume: 105, Issue:6

    Topics: Animals; Arrhythmias, Cardiac; Calmodulin; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; Heart Rate; Male; Methoxamine; Potassium Channel Blockers; Predictive Value of Tests; Quaternary Ammonium Compounds; Rabbits; Signal Processing, Computer-Assisted; Sulfonamides; Torsades de Pointes

2002
K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    European journal of pharmacology, 2007, Jan-19, Volume: 555, Issue:1

    Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Electrocardiography; Heart Rate; Long QT Syndrome; Male; Methoxamine; Potassium Channel Blockers; Quaternary Ammonium Compounds; Rabbits; Sodium Channel Blockers; Thiazepines; Torsades de Pointes

2007
Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 325, Issue:3

    Topics: Acetanilides; Action Potentials; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Female; Heart Rate; Lidocaine; Methoxamine; Phenylephrine; Piperazines; Potassium Channel Blockers; Prazosin; Quaternary Ammonium Compounds; Rabbits; Ranolazine; Torsades de Pointes

2008